In the last 12 months, insiders at BELITE BIO, INC ($BLTE) filed 119 transactions with the SEC: 0 open-market purchases totaling $0 and 112 sales totaling $5,666,629. Net insider sentiment: net selling.
BELITE BIO, INC operates in the Pharmaceutical preparations industry (Life sciences sector).
Most Active Insiders
- MATA NATHAN L. (Chief Scientific Officer) — 104 transactions totaling $2,673,514
- Lin Yu-Hsin (Chief Executive Officer) — 6 transactions totaling $1,669,339
- Chuang Hao-Yuan (Chief Financial Officer) — 6 transactions totaling $1,125,303
- Chen Wan-Shan (Not found) — 2 transactions totaling $198,473
- Scholl Hendrik Peter (Chief Medical Officer) — 1 transaction totaling $0
View all SEC Filings for BELITE BIO, INC (BLTE).
Set Up your own filters →Recent Insider Transactions
| Transaction Date | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|
| May 7, 2026 | MATA NATHAN L. | Chief Scientific Officer | S | American depositary share | 428 | $153.56 | 12.0000 | 33,538,160 | 97.27% | 0.00% |
| May 7, 2026 | MATA NATHAN L. | Chief Scientific Officer | S | American depositary share | 3 | $154.61 | 9.0000 | 33,538,160 | 25.00% | 0.00% |
| May 7, 2026 | MATA NATHAN L. | Chief Scientific Officer | S | American depositary share | 9 | $155.25 | 0.0000 | 33,538,160 | 100.00% | 0.00% |
| May 7, 2026 | MATA NATHAN L. | Chief Scientific Officer | S | American depositary share | 226 | $152.45 | 440.0000 | 33,538,160 | 33.93% | 0.00% |
| May 6, 2026 | MATA NATHAN L. | Chief Scientific Officer | S | American depositary share | 128 | $153.42 | 1,106.0000 | 33,538,160 | 10.37% | 0.00% |
| May 6, 2026 | MATA NATHAN L. | Chief Scientific Officer | S | American depositary share | 8 | $151.57 | 1,658.0000 | 33,538,160 | 0.48% | 0.00% |
| May 6, 2026 | MATA NATHAN L. | Chief Scientific Officer | S | American depositary share | 424 | $152.67 | 1,234.0000 | 33,538,160 | 25.57% | 0.00% |
| May 6, 2026 | MATA NATHAN L. | Chief Scientific Officer | S | American depositary share | 100 | $156.00 | 666.0000 | 33,538,160 | 13.05% | 0.00% |
| May 6, 2026 | MATA NATHAN L. | Chief Scientific Officer | S | American depositary share | 100 | $155.97 | 766.0000 | 33,538,160 | 11.55% | 0.00% |
| May 6, 2026 | MATA NATHAN L. | Chief Scientific Officer | S | American depositary share | 240 | $154.41 | 866.0000 | 33,538,160 | 21.70% | 0.00% |
| May 5, 2026 | MATA NATHAN L. | Chief Scientific Officer | S | American depositary share | 363 | $154.44 | 2,183.0000 | 33,538,160 | 14.26% | 0.00% |
| May 5, 2026 | MATA NATHAN L. | Chief Scientific Officer | S | American depositary share | 68 | $158.11 | 1,666.0000 | 33,538,160 | 3.92% | 0.00% |
| May 5, 2026 | MATA NATHAN L. | Chief Scientific Officer | S | American depositary share | 155 | $157.29 | 1,734.0000 | 33,538,160 | 8.21% | 0.00% |
| May 5, 2026 | MATA NATHAN L. | Chief Scientific Officer | S | American depositary share | 121 | $156.53 | 1,889.0000 | 33,538,160 | 6.02% | 0.00% |
| May 5, 2026 | MATA NATHAN L. | Chief Scientific Officer | S | American depositary share | 173 | $155.48 | 2,010.0000 | 33,538,160 | 7.92% | 0.00% |
| May 5, 2026 | MATA NATHAN L. | Chief Scientific Officer | S | American depositary share | 120 | $153.92 | 2,546.0000 | 33,538,160 | 4.50% | 0.00% |
| May 4, 2026 | MATA NATHAN L. | Chief Scientific Officer | S | American depositary share | 236 | $154.24 | 3,398.0000 | 33,538,160 | 6.49% | 0.00% |
| May 4, 2026 | MATA NATHAN L. | Chief Scientific Officer | S | American depositary share | 172 | $157.49 | 2,666.0000 | 33,538,160 | 6.06% | 0.00% |
| May 4, 2026 | MATA NATHAN L. | Chief Scientific Officer | S | American depositary share | 235 | $156.57 | 2,838.0000 | 33,538,160 | 7.65% | 0.00% |
| May 4, 2026 | MATA NATHAN L. | Chief Scientific Officer | S | American depositary share | 325 | $155.21 | 3,073.0000 | 33,538,160 | 9.56% | 0.00% |
| May 4, 2026 | MATA NATHAN L. | Chief Scientific Officer | S | American depositary share | 32 | $153.50 | 3,634.0000 | 33,538,160 | 0.87% | 0.00% |
| May 1, 2026 | MATA NATHAN L. | Chief Scientific Officer | S | American depositary share | 23 | $160.00 | 3,666.0000 | 33,538,160 | 0.62% | 0.00% |
| May 1, 2026 | MATA NATHAN L. | Chief Scientific Officer | S | American depositary share | 38 | $159.08 | 3,689.0000 | 33,538,160 | 1.02% | 0.00% |
| May 1, 2026 | MATA NATHAN L. | Chief Scientific Officer | S | American depositary share | 65 | $158.35 | 3,727.0000 | 33,538,160 | 1.71% | 0.00% |
| May 1, 2026 | MATA NATHAN L. | Chief Scientific Officer | S | American depositary share | 106 | $157.45 | 3,792.0000 | 33,538,160 | 2.72% | 0.00% |
| May 1, 2026 | MATA NATHAN L. | Chief Scientific Officer | S | American depositary share | 82 | $156.24 | 3,898.0000 | 33,538,160 | 2.06% | 0.00% |
| May 1, 2026 | MATA NATHAN L. | Chief Scientific Officer | S | American depositary share | 346 | $155.48 | 3,980.0000 | 33,538,160 | 8.00% | 0.00% |
| May 1, 2026 | MATA NATHAN L. | Chief Scientific Officer | S | American depositary share | 288 | $154.38 | 4,326.0000 | 33,538,160 | 6.24% | 0.00% |
| May 1, 2026 | MATA NATHAN L. | Chief Scientific Officer | S | American depositary share | 52 | $153.89 | 4,614.0000 | 33,538,160 | 1.11% | 0.00% |
| April 30, 2026 | MATA NATHAN L. | Chief Scientific Officer | S | American depositary share | 101 | $158.15 | 4,666.0000 | 33,538,160 | 2.12% | 0.00% |
| April 30, 2026 | MATA NATHAN L. | Chief Scientific Officer | S | American depositary share | 340 | $157.37 | 4,767.0000 | 33,538,160 | 6.66% | 0.00% |
| April 30, 2026 | MATA NATHAN L. | Chief Scientific Officer | S | American depositary share | 517 | $156.59 | 5,107.0000 | 33,538,160 | 9.19% | 0.00% |
| April 30, 2026 | MATA NATHAN L. | Chief Scientific Officer | S | American depositary share | 42 | $155.68 | 5,624.0000 | 33,538,160 | 0.74% | 0.00% |
| April 29, 2026 | MATA NATHAN L. | Chief Scientific Officer | S | American depositary share | 278 | $154.58 | 6,388.0000 | 33,538,160 | 4.17% | 0.00% |
| April 29, 2026 | MATA NATHAN L. | Chief Scientific Officer | S | American depositary share | 259 | $155.52 | 6,129.0000 | 33,538,160 | 4.05% | 0.00% |
| April 29, 2026 | MATA NATHAN L. | Chief Scientific Officer | S | American depositary share | 22 | $158.19 | 5,666.0000 | 33,538,160 | 0.39% | 0.00% |
| April 29, 2026 | MATA NATHAN L. | Chief Scientific Officer | S | American depositary share | 102 | $157.39 | 5,688.0000 | 33,538,160 | 1.76% | 0.00% |
| April 29, 2026 | MATA NATHAN L. | Chief Scientific Officer | S | American depositary share | 339 | $156.43 | 5,790.0000 | 33,538,160 | 5.53% | 0.00% |
| April 28, 2026 | MATA NATHAN L. | Chief Scientific Officer | S | American depositary share | 89 | $161.72 | 6,720.0000 | 33,538,160 | 1.31% | 0.00% |
| April 28, 2026 | MATA NATHAN L. | Chief Scientific Officer | S | American depositary share | 54 | $162.14 | 6,666.0000 | 33,538,160 | 0.80% | 0.00% |
| April 28, 2026 | MATA NATHAN L. | Chief Scientific Officer | S | American depositary share | 62 | $158.71 | 7,309.0000 | 33,538,160 | 0.84% | 0.00% |
| April 28, 2026 | MATA NATHAN L. | Chief Scientific Officer | S | American depositary share | 222 | $157.49 | 7,371.0000 | 33,538,160 | 2.92% | 0.00% |
| April 28, 2026 | MATA NATHAN L. | Chief Scientific Officer | S | American depositary share | 53 | $156.61 | 7,593.0000 | 33,538,160 | 0.69% | 0.00% |
| April 28, 2026 | MATA NATHAN L. | Chief Scientific Officer | S | American depositary share | 8 | $155.36 | 7,646.0000 | 33,538,160 | 0.10% | 0.00% |
| April 28, 2026 | MATA NATHAN L. | Chief Scientific Officer | S | American depositary share | 12 | $154.65 | 7,654.0000 | 33,538,160 | 0.16% | 0.00% |
| April 28, 2026 | MATA NATHAN L. | Chief Scientific Officer | S | American depositary share | 120 | $160.27 | 6,809.0000 | 33,538,160 | 1.73% | 0.00% |
| April 28, 2026 | MATA NATHAN L. | Chief Scientific Officer | S | American depositary share | 380 | $159.42 | 6,929.0000 | 33,538,160 | 5.20% | 0.00% |
| April 27, 2026 | MATA NATHAN L. | Chief Scientific Officer | S | American depositary share | 280 | $161.62 | 8,342.0000 | 33,538,160 | 3.25% | 0.00% |
| April 27, 2026 | MATA NATHAN L. | Chief Scientific Officer | S | American depositary share | 409 | $163.56 | 7,702.0000 | 33,538,160 | 5.04% | 0.00% |
| April 27, 2026 | MATA NATHAN L. | Chief Scientific Officer | S | American depositary share | 231 | $162.38 | 8,111.0000 | 33,538,160 | 2.77% | 0.00% |
| April 27, 2026 | MATA NATHAN L. | Chief Scientific Officer | S | American depositary share | 44 | $160.83 | 8,622.0000 | 33,538,160 | 0.51% | 0.00% |
| April 27, 2026 | MATA NATHAN L. | Chief Scientific Officer | S | American depositary share | 36 | $164.07 | 7,666.0000 | 33,538,160 | 0.47% | 0.00% |
| April 24, 2026 | MATA NATHAN L. | Chief Scientific Officer | S | American depositary share | 74 | $157.86 | 9,592.0000 | 33,538,160 | 0.77% | 0.00% |
| April 24, 2026 | MATA NATHAN L. | Chief Scientific Officer | S | American depositary share | 375 | $159.46 | 9,027.0000 | 33,538,160 | 3.99% | 0.00% |
| April 24, 2026 | MATA NATHAN L. | Chief Scientific Officer | S | American depositary share | 3 | $162.53 | 8,666.0000 | 33,538,160 | 0.03% | 0.00% |
| April 24, 2026 | MATA NATHAN L. | Chief Scientific Officer | S | American depositary share | 28 | $161.22 | 8,669.0000 | 33,538,160 | 0.32% | 0.00% |
| April 24, 2026 | MATA NATHAN L. | Chief Scientific Officer | S | American depositary share | 190 | $158.65 | 9,402.0000 | 33,538,160 | 1.98% | 0.00% |
| April 24, 2026 | MATA NATHAN L. | Chief Scientific Officer | S | American depositary share | 330 | $160.40 | 8,697.0000 | 33,538,160 | 3.66% | 0.00% |
| April 23, 2026 | MATA NATHAN L. | Chief Scientific Officer | S | American depositary share | 54 | $168.43 | 9,687.0000 | 33,538,160 | 0.55% | 0.00% |
| April 23, 2026 | MATA NATHAN L. | Chief Scientific Officer | S | American depositary share | 267 | $164.47 | 10,399.0000 | 33,538,160 | 2.50% | 0.00% |
| April 23, 2026 | MATA NATHAN L. | Chief Scientific Officer | S | American depositary share | 158 | $165.38 | 10,241.0000 | 33,538,160 | 1.52% | 0.00% |
| April 23, 2026 | MATA NATHAN L. | Chief Scientific Officer | S | American depositary share | 127 | $166.56 | 10,114.0000 | 33,538,160 | 1.24% | 0.00% |
| April 23, 2026 | MATA NATHAN L. | Chief Scientific Officer | S | American depositary share | 373 | $167.37 | 9,741.0000 | 33,538,160 | 3.69% | 0.00% |
| April 23, 2026 | MATA NATHAN L. | Chief Scientific Officer | S | American depositary share | 21 | $169.56 | 9,666.0000 | 33,538,160 | 0.22% | 0.00% |
| April 21, 2026 | Lin Yu-Hsin | Chief Executive Officer | J | Ordinary Share | 10000 | $0.00 | 182,949.0000 | 33,538,160 | 5.78% | 0.03% |
| April 21, 2026 | Chuang Hao-Yuan | Chief Financial Officer | J | Ordinary Share | 10000 | $0.00 | 205,264.0000 | 33,538,160 | 5.12% | 0.03% |
| April 22, 2026 | MATA NATHAN L. | Chief Scientific Officer | S | American depositary share | 21 | $173.04 | 10,666.0000 | 33,538,160 | 0.20% | 0.00% |
| April 22, 2026 | MATA NATHAN L. | Chief Scientific Officer | S | American depositary share | 249 | $172.49 | 10,687.0000 | 33,538,160 | 2.28% | 0.00% |
| April 22, 2026 | MATA NATHAN L. | Chief Scientific Officer | S | American depositary share | 257 | $171.62 | 10,936.0000 | 33,538,160 | 2.30% | 0.00% |
| April 22, 2026 | MATA NATHAN L. | Chief Scientific Officer | S | American depositary share | 75 | $170.58 | 11,193.0000 | 33,538,160 | 0.67% | 0.00% |
| April 22, 2026 | MATA NATHAN L. | Chief Scientific Officer | S | American depositary share | 105 | $169.52 | 11,268.0000 | 33,538,160 | 0.92% | 0.00% |
| April 22, 2026 | MATA NATHAN L. | Chief Scientific Officer | S | American depositary share | 101 | $168.64 | 11,373.0000 | 33,538,160 | 0.88% | 0.00% |
| April 22, 2026 | MATA NATHAN L. | Chief Scientific Officer | S | American depositary share | 141 | $167.42 | 11,474.0000 | 33,538,160 | 1.21% | 0.00% |
| April 22, 2026 | MATA NATHAN L. | Chief Scientific Officer | S | American depositary share | 20 | $166.32 | 11,615.0000 | 33,538,160 | 0.17% | 0.00% |
| April 22, 2026 | MATA NATHAN L. | Chief Scientific Officer | S | American depositary share | 31 | $165.70 | 11,635.0000 | 33,538,160 | 0.27% | 0.00% |
| April 21, 2026 | Scholl Hendrik Peter | Chief Medical Officer | J | Stock Option (right to buy) | 10000 | $0.00 | 10,000.0000 | 33,538,160 | 9999.99% | 0.03% |
| April 21, 2026 | MATA NATHAN L. | Chief Scientific Officer | S | American depositary share | 78 | $164.60 | 12,524.0000 | 33,538,160 | 0.62% | 0.00% |
| April 21, 2026 | MATA NATHAN L. | Chief Scientific Officer | S | American depositary share | 214 | $167.34 | 11,666.0000 | 33,538,160 | 1.80% | 0.00% |
| April 21, 2026 | MATA NATHAN L. | Chief Scientific Officer | S | American depositary share | 312 | $166.49 | 11,880.0000 | 33,538,160 | 2.56% | 0.00% |
| April 21, 2026 | MATA NATHAN L. | Chief Scientific Officer | S | American depositary share | 332 | $165.49 | 12,192.0000 | 33,538,160 | 2.65% | 0.00% |
| April 21, 2026 | MATA NATHAN L. | Chief Scientific Officer | S | American depositary share | 64 | $163.49 | 12,602.0000 | 33,538,160 | 0.51% | 0.00% |
| April 20, 2026 | MATA NATHAN L. | Chief Scientific Officer | S | American depositary share | 524 | $163.52 | 12,858.0000 | 33,538,160 | 3.92% | 0.00% |
| April 20, 2026 | MATA NATHAN L. | Chief Scientific Officer | S | American depositary share | 9 | $168.35 | 12,666.0000 | 33,538,160 | 0.07% | 0.00% |
| April 20, 2026 | MATA NATHAN L. | Chief Scientific Officer | S | American depositary share | 16 | $167.17 | 12,675.0000 | 33,538,160 | 0.13% | 0.00% |
| April 20, 2026 | MATA NATHAN L. | Chief Scientific Officer | S | American depositary share | 3 | $166.91 | 12,691.0000 | 33,538,160 | 0.02% | 0.00% |
| April 20, 2026 | MATA NATHAN L. | Chief Scientific Officer | S | American depositary share | 40 | $165.29 | 12,694.0000 | 33,538,160 | 0.31% | 0.00% |
| April 20, 2026 | MATA NATHAN L. | Chief Scientific Officer | S | American depositary share | 124 | $164.40 | 12,734.0000 | 33,538,160 | 0.96% | 0.00% |
| April 20, 2026 | MATA NATHAN L. | Chief Scientific Officer | S | American depositary share | 284 | $162.76 | 13,382.0000 | 33,538,160 | 2.08% | 0.00% |
| April 17, 2026 | MATA NATHAN L. | Chief Scientific Officer | S | American depositary share | 216 | $162.48 | 13,866.0000 | 33,538,160 | 1.53% | 0.00% |
| April 16, 2026 | MATA NATHAN L. | Chief Scientific Officer | S | American depositary share | 12 | $164.12 | 14,666.0000 | 33,538,160 | 0.08% | 0.00% |
| April 16, 2026 | MATA NATHAN L. | Chief Scientific Officer | S | American depositary share | 36 | $163.21 | 14,678.0000 | 33,538,160 | 0.24% | 0.00% |
| April 16, 2026 | MATA NATHAN L. | Chief Scientific Officer | S | American depositary share | 76 | $162.26 | 14,714.0000 | 33,538,160 | 0.51% | 0.00% |
| April 16, 2026 | MATA NATHAN L. | Chief Scientific Officer | S | American depositary share | 240 | $161.61 | 14,790.0000 | 33,538,160 | 1.60% | 0.00% |
| April 16, 2026 | MATA NATHAN L. | Chief Scientific Officer | S | American depositary share | 201 | $160.35 | 15,030.0000 | 33,538,160 | 1.32% | 0.00% |
| April 16, 2026 | MATA NATHAN L. | Chief Scientific Officer | S | American depositary share | 219 | $159.81 | 15,231.0000 | 33,538,160 | 1.42% | 0.00% |
| April 16, 2026 | MATA NATHAN L. | Chief Scientific Officer | S | American depositary share | 216 | $158.28 | 15,450.0000 | 33,538,160 | 1.38% | 0.00% |
| April 17, 2026 | MATA NATHAN L. | Chief Scientific Officer | S | American depositary share | 200 | $163.33 | 13,666.0000 | 33,538,160 | 1.44% | 0.00% |
| April 17, 2026 | MATA NATHAN L. | Chief Scientific Officer | S | American depositary share | 274 | $161.41 | 14,082.0000 | 33,538,160 | 1.91% | 0.00% |
| April 17, 2026 | MATA NATHAN L. | Chief Scientific Officer | S | American depositary share | 226 | $160.55 | 14,356.0000 | 33,538,160 | 1.55% | 0.00% |
| April 17, 2026 | MATA NATHAN L. | Chief Scientific Officer | S | American depositary share | 52 | $159.38 | 14,582.0000 | 33,538,160 | 0.36% | 0.00% |
| April 17, 2026 | MATA NATHAN L. | Chief Scientific Officer | S | American depositary share | 32 | $158.46 | 14,634.0000 | 33,538,160 | 0.22% | 0.00% |
| April 15, 2026 | MATA NATHAN L. | Chief Scientific Officer | S | American depositary share | 383 | $167.58 | 16,283.0000 | 33,538,160 | 2.30% | 0.00% |
| April 15, 2026 | MATA NATHAN L. | Chief Scientific Officer | S | American depositary share | 8 | $170.77 | 15,670.0000 | 33,538,160 | 0.05% | 0.00% |
| April 15, 2026 | MATA NATHAN L. | Chief Scientific Officer | S | American depositary share | 68 | $169.15 | 15,678.0000 | 33,538,160 | 0.43% | 0.00% |
| April 15, 2026 | MATA NATHAN L. | Chief Scientific Officer | S | American depositary share | 537 | $168.64 | 15,746.0000 | 33,538,160 | 3.30% | 0.00% |
| April 15, 2026 | MATA NATHAN L. | Chief Scientific Officer | S | American depositary share | 4 | $171.19 | 15,666.0000 | 33,538,160 | 0.03% | 0.00% |
| April 9, 2026 | Chuang Hao-Yuan | Chief Financial Officer | S | American depositary share | 2000 | $180.35 | 98,000.0000 | 33,538,160 | 2.00% | 0.01% |
| April 9, 2026 | Chen Wan-Shan | Not found | S | American depositary share | 1100 | $180.43 | 9,096.0000 | 33,538,160 | 10.79% | 0.00% |
| April 9, 2026 | Lin Yu-Hsin | Chief Executive Officer | S | American depositary share | 200 | $183.00 | 170,934.0000 | 33,538,160 | 0.12% | 0.00% |
| April 9, 2026 | Lin Yu-Hsin | Chief Executive Officer | S | American depositary share | 3000 | $182.40 | 171,134.0000 | 33,538,160 | 1.72% | 0.01% |
| April 9, 2026 | Lin Yu-Hsin | Chief Executive Officer | S | American depositary share | 3500 | $181.33 | 174,134.0000 | 33,538,160 | 1.97% | 0.01% |
| April 9, 2026 | Lin Yu-Hsin | Chief Executive Officer | S | American depositary share | 2500 | $180.36 | 177,634.0000 | 33,538,160 | 1.39% | 0.01% |
| April 9, 2026 | Chuang Hao-Yuan | Chief Financial Officer | S | American depositary share | 291 | $183.08 | 93,800.0000 | 33,538,160 | 0.31% | 0.00% |
| April 9, 2026 | Chuang Hao-Yuan | Chief Financial Officer | S | American depositary share | 1909 | $182.58 | 94,091.0000 | 33,538,160 | 1.99% | 0.01% |
| April 9, 2026 | Chuang Hao-Yuan | Chief Financial Officer | S | American depositary share | 2000 | $181.40 | 96,000.0000 | 33,538,160 | 2.04% | 0.01% |
| March 31, 2026 | MATA NATHAN L. | Chief Scientific Officer | A | Stock Option (right to buy) | 144868 | $0.00 | 267,934.0000 | 33,538,160 | 117.72% | 0.43% |
| March 31, 2026 | Chen Wan-Shan | Not found | A | Stock Option (right to buy) | 13796 | $0.00 | 13,796.0000 | 33,538,160 | 9999.99% | 0.04% |
| March 31, 2026 | Lin Yu-Hsin | Chief Executive Officer | A | Stock Option (right to buy) | 206954 | $0.00 | 413,908.0000 | 33,538,160 | 100.00% | 0.62% |
| March 31, 2026 | Chuang Hao-Yuan | Chief Financial Officer | A | Stock Option (right to buy) | 144868 | $0.00 | 289,736.0000 | 33,538,160 | 100.00% | 0.43% |